Stephen Fesik Archives
Event to spotlight VUMC’s COVID-19 research efforts
Nov. 3, 2022—The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.
VICC researchers featured at AACR Annual Meeting
Apr. 8, 2021—Researchers from Vanderbilt-Ingram Cancer Center will have a robust presence during the first session of the American Association for Cancer Research (AACR) Annual Meeting, April 10-15, as presenters, panelists and authors.
Cancer’s SOS
Mar. 28, 2019—Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.
Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
Mar. 14, 2018—New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.
VU takes key role in cancer drug discovery consortium
Jun. 23, 2016—Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery.
VICC investigators in spotlight at AACR conference
May. 19, 2016—A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.
‘Docking stations’ on chromosomes new anti-cancer target
Mar. 26, 2015—Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks.
Grant bolsters pancreatic cancer drug discovery efforts
Jan. 29, 2015—The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.
A new way to target cancer-driver Ras
Mar. 13, 2014—Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.
Next My Health Chat to explore cancer drug discovery
Mar. 19, 2012—The April program for My Health Chat will be the promising world of cancer drug discovery. Panelists will be Lawrence Marnett, director of the Vanderbilt Institute of Chemical Biology, and Stephen Fesik, director of drug discovery at Vanderbilt-Ingram Cancer Center. They will discuss and take questions regarding how information about the genetic drivers of cancer...
Seven Vanderbilt University Faculty Honored by AAAS Scientific Society
Jan. 12, 2011—Seven Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science, an honor bestowed upon them by their AAAS peers. They are among 503 AAAS members from around the country who achieved this honor because of their distinguished efforts to advance science or its applications. The newest AAAS...
